Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: onr:"swepub:oai:DiVA.org:uu-425474" > Management of patie...

1 av 1
Föregående post
Nästa post
Till träfflistan

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		04227naa a2200589 4500
001		oai:DiVA.org:uu-425474
003		SwePub
008		201116s2021 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
009		oai:prod.swepub.kib.ki.se:146832706
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4254742 URI
024	7	a https://doi.org/10.1093/ehjcvp/pvaa0402 DOI
024	7	a http://kipublications.ki.se/Default.aspx?queryparsed=id:1468327062 URI
040		a (SwePub)uud (SwePub)ki
041		a engb eng
042		9 SwePub
072	7	a vet2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Mancusi, Costantino4 aut
245	1 0	a Management of patients with combined arterial hypertension and aortic valve stenosis :b a consensus document from the Council on Hypertension and Council on Valvular Heart Disease of the European Society of Cardiology, the European Association of Cardiovascular Imaging (EACVI), the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
264		c 2020-04-30
264	1	b Oxford University Press,c 2021
338		a print2 rdacarrier
520		a Aortic valve stenosis (AS) is the third most common cardiovascular disease. The prevalence of both AS and arterial hypertension increases with age, and the conditions therefore often co-exist. Co-existence of AS and arterial hypertension is associated with higher global left ventricular (LV) pressure overload, more abnormal LV geometry and function, and more adverse cardiovascular outcome. Arterial hypertension may also influence grading of AS, leading to underestimation of the true AS severity. Current guidelines suggest re-assessing patients once arterial hypertension is controlled. Management of arterial hypertension in AS has historically been associated with prudence and concerns, mainly related to potential adverse consequences of drug-induced peripheral vasodilatation combined with reduced stroke volume due to the fixed LV outflow obstruction. Current evidence suggests that patients should be treated with antihypertensive drugs blocking the renin-angiotensin aldosterone system, adding further drug classes when required, to achieve similar target blood pressure values as in hypertensive patients without AS. The introduction of trans-catheter aortic valve implantation has revolutionized the management of patients with AS, but requires proper blood pressure management during and following valve replacement. The purpose of this document is to review the recent evidence and provide practical expert advice on management of hypertension in patients with AS.
650	7	a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Kardiologi0 (SwePub)302062 hsv//swe
650	7	a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Cardiac and Cardiovascular Systems0 (SwePub)302062 hsv//eng
653		a Aortic valve stenosis
653		a aortic valve calcification
653		a aortic valve replacement
653		a arterial hypertension
653		a cardiovascular risk
653		a drug therapy
653		a left ventricular hypertrophy
653		a prognosis
653		a Kardiologi
653		a Cardiology
700	1	a de Simone, Giovanni4 aut
700	1	a Brguljan Hitij, Jana4 aut
700	1	a Sudano, Isabella4 aut
700	1	a Mahfoud, Felix4 aut
700	1	a Parati, Gianfranco4 aut
700	1	a Kahan, Thomasu Karolinska Institutet4 aut
700	1	a Barbato, Emanuele4 aut
700	1	a Pierard, Luc A.4 aut
700	1	a Garbi, Madalina4 aut
700	1	a Flachskampf, Frank,d 1957-u Uppsala universitet,Klinisk fysiologi,Kardiologi4 aut0 (Swepub:uu)frafl698
700	1	a Gerdts, Eva4 aut
710	2	a Karolinska Institutetb Klinisk fysiologi4 org
773	0	t European Heart Journal - Cardiovascular Pharmacotherapyd : Oxford University Pressg 7:3, s. 242-250q 7:3<242-250x 2055-6837x 2055-6845
856	4	u https://academic.oup.com/ehjcvp/advance-article-pdf/doi/10.1093/ehjcvp/pvaa040/33439125/pvaa040.pdf
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-425474
856	4 8	u https://doi.org/10.1093/ehjcvp/pvaa040
856	4 8	u http://kipublications.ki.se/Default.aspx?queryparsed=id:146832706

Hitta via bibliotek

European Heart Journal - Cardiovascular Pharmacotherapy (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

1 av 1
Föregående post
Nästa post
Till träfflistan

Hitta mer i SwePub

Av författaren/redakt...: Mancusi, Costant ...; de Simone, Giova ...; Brguljan Hitij, ...; Sudano, Isabella; Mahfoud, Felix; Parati, Gianfran ...; visa fler...; Kahan, Thomas; Barbato, Emanuel ...; Pierard, Luc A.; Garbi, Madalina; Flachskampf, Fra ...; Gerdts, Eva; visa färre...

Om ämnet

MEDICIN OCH HÄLSOVETENSKAP: MEDICIN OCH HÄLS ...; och Klinisk medicin; och Kardiologi

Artiklar i publikationen: European Heart J ...

Av lärosätet: Uppsala universitet; Karolinska Institutet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se